FTC gives Medtronic, Covidien merger the green light
November 26, 2014 by Brian Johnson
The U.S. Federal Trade Commission has approved the pending $43 billion merger between Medtronic and Covidien, according to regulatory filings.
“This regulatory clearance represents an important milestone in bringing our companies together,” said Omar Ishrak, Chairman and CEO of Medtronic in a prepared release. Read more
EU regulators clear Medtronic's Covidien buy
December 1, 2014 by Brad Perriello
Medtronic said last week that its proposed, $43 billion acquisition of Covidien cleared anti-trust hurdles in the Europe.
The approval, announced Nov. 28, came 2 days after the U.S. Federal Trade Commission granted its benison for the deal. Read more
Medtronic prices $17B debt offering for Covidien buy
December 1, 2014 by Brad Perriello
Medtronic took another big step today toward consummating its $43 billion bid for Covidien, saying it priced priced $17 billion worth of debt to finance the deal.
The 7-tranche offering of senior notes, expected to close Dec. 10, start coming due in 2020, with the final tranche due March 15, 2045, Medtronic said. The proceeds will be used to fund the cash portion of the Covidien buy, the Fridley, Minn.-based company said. Read more
